Your browser doesn't support javascript.
loading
Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.
Kobayashi, Sumiko; Ueda, Yasunori; Nannya, Yasuhito; Shibayama, Hirohiko; Tamura, Hideto; Ogata, Kiyoyuki; Akatsuka, Yoshiki; Usuki, Kensuke; Ito, Yoshikazu; Okada, Masaya; Suzuki, Takahiro; Hata, Tomoko; Matsuda, Akira; Tohyama, Kaoru; Kakumoto, Keiji; Koga, Daisuke; Mitani, Kinuko; Naoe, Tomoki; Sugiyama, Haruo; Takaku, Fumimaro.
Afiliación
  • Kobayashi S; Department of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Ueda Y; Department of Haematology/Oncology, Transfusion and Haemapheresis Center, Kurashiki Central Hospital, Okayama, Japan.
  • Nannya Y; Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Shibayama H; Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Tamura H; Division of Hematology, Department of Medicine, Nippon Medical School, Tokyo, Japan.
  • Ogata K; Division of Hematology, Department of Medicine, Nippon Medical School, Tokyo, Japan.
  • Akatsuka Y; Department of Hematology, Shin-Yurigaoka General Hospital, Kanagawa, Japan.
  • Usuki K; Department of Hematology, Fujita Health University School of Medicine, Aichi, Japan.
  • Ito Y; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Okada M; Department of Hematology, Tokyo Medical University Hospital, Tokyo, Japan.
  • Suzuki T; Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.
  • Hata T; Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Matsuda A; Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Tohyama K; Department of Hemato-Oncology, Saitama International Medical Center, Saitama Medical University, Saitama, Japan.
  • Kakumoto K; Department of Laboratory Medicine, Kawasaki Medical School, Okayama, Japan.
  • Koga D; Information Management Office, Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
  • Mitani K; Diagnostic Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
  • Naoe T; Department of Hematology and Oncology, Dokkyo Medical University School of Medicine, Tochigi, Japan.
  • Sugiyama H; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Takaku F; National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Cancer Biomark ; 17(1): 21-32, 2016 Mar 31.
Article en En | MEDLINE | ID: mdl-27062571
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / ARN Mensajero / Proteínas WT1 Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Biomark Asunto de la revista: BIOQUIMICA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / ARN Mensajero / Proteínas WT1 Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Biomark Asunto de la revista: BIOQUIMICA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos